Coumarin-3-carboxylic acid derivatives as potentiators and inhibitors of recombinant and native N-methyl-d-aspartate receptors
- 1 September 2012
- journal article
- Published by Elsevier in Neurochemistry International
- Vol. 61 (4) , 593-600
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- A Novel Family of Negative and Positive Allosteric Modulators of NMDA ReceptorsThe Journal of Pharmacology and Experimental Therapeutics, 2010
- A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptorsNature Communications, 2010
- Glutamate Receptor Ion Channels: Structure, Regulation, and FunctionPharmacological Reviews, 2010
- Quinazolin-4-one Derivatives: A Novel Class of Noncompetitive NR2C/D Subunit-SelectiveN-Methyl-d-aspartate Receptor AntagonistsJournal of Medicinal Chemistry, 2010
- X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptorNature, 2009
- N-Methyl-d-aspartate (NMDA) Receptor NR2 Subunit Selectivity of a Series of Novel Piperazine-2,3-dicarboxylate Derivatives: Preferential Blockade of Extrasynaptic NMDA Receptors in the Rat Hippocampal CA3-CA1 SynapseThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disordersNature Reviews Drug Discovery, 2009
- NMDA receptors in clinical neurology: excitatory times aheadThe Lancet Neurology, 2008
- Prion protein attenuates excitotoxicity by inhibiting NMDA receptorsJournal of General Physiology, 2008
- Targeting the glutamatergic system to develop novel, improved therapeutics for mood disordersNature Reviews Drug Discovery, 2008